Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:abbreviation |
gptkb:BGV
|
| gptkbp:country |
gptkb:Netherlands
|
| gptkbp:focusesOn |
gptkb:biotechnology
life sciences healthcare startups |
| gptkbp:foundedIn |
2006
|
| gptkbp:headquartersLocation |
gptkb:Naarden
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioGeneration Ventures
|
| gptkbp:investedIn |
early-stage companies
|
| gptkbp:managingPartner |
Edward van Wezel
|
| gptkbp:portfolioCompany |
gptkb:Confo_Therapeutics
gptkb:Acerta_Pharma gptkb:Synaffix NorthSea Therapeutics Amylon Therapeutics Staten Biotechnology VarmX Versameb |
| gptkbp:regionServed |
gptkb:Europe
|
| gptkbp:website |
https://www.biogenerationventures.com/
|
| gptkbp:bfsParent |
gptkb:Confo_Therapeutics
gptkb:Vico_Therapeutics |
| gptkbp:bfsLayer |
8
|